Meningococcal Disease Due to Neisseria Meningitidis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-06-26
Clinical Trial Update: Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age [Phase 3]
Phase 3 immunogenicity and safety study comparing Hib-MenCY-TT (MenHibrix) to PedvaxHIB in healthy infants and toddlers; study completed wit…